A Retrospective Study of Subjects With Thymidine Kinase 2 Deficiency

Completed

Conditions studied: Thymidine Kinase 2 Deficiency

In brief

This is a multicenter, multinational, retrospective chart-review study to evaluate survival in patients with Thymidine Kinase 2 deficiency (TK2d).

Key facts

Study ID

NCT05017818

Run by

Zogenix MDS, Inc.

People needed

61

Starts

2021-07-23

Expected to finish

2022-01-21

Last updated by the study team

2023-09-01

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed informed consent by the subject or parent(s)/LAR and/or assent by the subject (when applicable), unless the associated IRB or EC provides an appropriate consent waiver that allows review of medical records for this study.
• Confirmed genetic mutations in the TK2 gene.
• Availability of medical records or information pertaining to vital status at a minimum.

You may not qualify if…

• Not applicable as this is a non-interventional study.

Where it is running

• David Geffen School of Medicine at UCLA — Los Angeles, California, United States
• Indiana University School of Medicine — Indianapolis, Indiana, United States
• Akron Children's Hospital — Akron, Ohio, United States
• East Tennessee Childrens Hospital — Knoxville, Tennessee, United States
• Medical Center Zdorovyy Rebenok — Voronezh, Voronezh Oblast, Russia
• NIKI Pediatrii im Veltischeva, Children's Neuromuscular center — Moscow, Russia
• Vall d'Hebron Institut de Recerca — Barcelona, Spain
• Hospital Clínic Barcelona — Barcelona, Spain
• Hospital de la Santa Creu i Sant Pau — Barcelona, Spain
• Hospital Universitario 12 de Octubre — Madrid, Spain
• Istanbul Universitesi, Istanbul Tip Fakultesi — Fatih, Istanbul, Turkey (Türkiye)
• Yeditepe University Koşuyolu Hospital — Kadiköy, Turkey (Türkiye)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.